DprE1-IN-1

• CAT Number: I001841
• CAS Number: 1494675-86-3
• Molecular Formula: C18H21N5O3
• Molecular Weight: 355.40
• Purity: ≥95%
• Synonyms: N-(2-hydroxyethyl)-1-[(6-methoxy-5-methyl-4-pyrimidinyl)methyl]-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide
• Target: DprE1
• Solubility: DMSO: ≤ 11 mg/mL
• Storage: Store at -20°C
• IC50: 10 nM [1]
• IUPAC Name: N-(2-hydroxyethyl)-1-[(6-methoxy-5-methylpyrimidin-4-yl)methyl]-6-methylpyrrolo[3,2-b]pyridine-3-carboxamide
• InChI: InChI=1S/C18H21N5O3/c1-11-6-15-16(20-7-11)13(17(25)19-4-5-24)8-23(15)9-14-12(2)18(26-3)22-10-21-14/h6-8,10,24H,4-5,9H2,1-3H3,(H,19,25)
• InChIKey: VDRYGTNDKXIPSK-UHFFFAOYSA-N
• SMILES: CC1=CC2=C(C(=CN2CC3=C(C(=NC=N3)OC)C)C(=O)NCCO)N=C1

DprE1-IN-1（Cat No.:I001841）is a potent inhibitor targeting DprE1, an essential enzyme in the biosynthesis of the mycobacterial cell wall, making it a promising candidate in tuberculosis research. By inhibiting DprE1, DprE1-IN-1 disrupts the synthesis of arabinogalactan, a critical component of the mycobacterial cell wall, ultimately leading to bacterial cell death. This compound has shown significant efficacy against Mycobacterium tuberculosis, including drug-resistant strains, offering potential as an anti-tubercular agent. DprE1-IN-1 is valuable in drug development for tackling persistent and resistant forms of tuberculosis.

Reference

[1]. Shirude PS, et al. Lead optimization of 1,4-azaindoles as antimycobacterial agents. J Med Chem. 2014 Jul 10;57(13):5728-37.
[2]. Chatterji M, et al. 1,4-azaindole, a potential drug candidate for treatment of tuberculosis. Antimicrob Agents Chemother. 2014 Sep;58(9):5325-31.